Goldman Sachs’s Incyte INCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-21,000
| Closed | -$1.43M | – | 6490 |
|
|
2025
Q2 | $1.43M | Buy |
+21,000
| New | +$1.33M | ﹤0.01% | 4434 |
|
|
2024
Q4 | – | Sell |
-26,900
| Closed | -$1.78M | – | 6148 |
|
|
2024
Q3 | $1.78M | Sell |
26,900
-30,000
| -53% | -$1.91M | ﹤0.01% | 4253 |
|
|
2024
Q2 | $3.45M | Buy |
56,900
+44,700
| +366% | +$2.53M | ﹤0.01% | 3494 |
|
|
2024
Q1 | $695K | Sell |
12,200
-87,800
| -88% | -$5.27M | ﹤0.01% | 4566 |
|
|
2023
Q4 | $6.28M | Hold |
100,000
| – | – | ﹤0.01% | 2973 |
|
|
2023
Q3 | $5.78M | Sell |
100,000
-28,100
| -22% | -$1.77M | ﹤0.01% | 2853 |
|
|
2023
Q2 | $7.97M | Buy |
128,100
+58,100
| +83% | +$3.88M | ﹤0.01% | 2672 |
|
|
2023
Q1 | $5.06M | Buy |
70,000
+40,100
| +134% | +$3.14M | ﹤0.01% | 3054 |
|
|
2022
Q4 | $2.4M | Buy |
+29,900
| New | +$2.29M | ﹤0.01% | 3801 |
|
|
2020
Q3 | – | Sell |
-30,000
| Closed | -$3.12M | – | 5425 |
|
|
2020
Q2 | $3.12M | Buy |
+30,000
| New | +$2.89M | ﹤0.01% | 3140 |
|
|
2020
Q1 | – | Sell |
-92,200
| Closed | -$8.05M | – | 5371 |
|
|
2019
Q4 | $8.05M | Sell |
92,200
-24,600
| -21% | -$2.1M | ﹤0.01% | 2592 |
|
|
2019
Q3 | $8.67M | Buy |
116,800
+32,900
| +39% | +$2.66M | ﹤0.01% | 2428 |
|
|
2019
Q2 | $7.13M | Buy |
+83,900
| New | +$6.73M | ﹤0.01% | 2605 |
|
|
2018
Q2 | – | Sell |
-31,100
| Closed | -$2.59M | – | 5822 |
|
|
2018
Q1 | $2.59M | Sell |
31,100
-84,300
| -73% | -$7.6M | ﹤0.01% | 3406 |
|
|
2017
Q4 | $10.9M | Buy |
115,400
+39,400
| +52% | +$4.12M | ﹤0.01% | 2397 |
|
|
2017
Q3 | $8.87M | Buy |
+76,000
| New | +$9.62M | ﹤0.01% | 2659 |
|
|
2017
Q2 | – | Sell |
-112,000
| Closed | -$15M | – | 6848 |
|
|
2017
Q1 | $15M | Buy |
112,000
+58,900
| +111% | +$7.5M | ﹤0.01% | 2101 |
|
|
2016
Q4 | $5.32M | Sell |
53,100
-126,900
| -71% | -$12.4M | ﹤0.01% | 2997 |
|
|
2016
Q3 | $17M | Hold |
180,000
| – | – | 0.01% | 2030 |
|
|
2016
Q2 | $14.4M | Sell |
180,000
-30,000
| -14% | -$2.33M | ﹤0.01% | 2043 |
|
|
2016
Q1 | $15.2M | Sell |
210,000
-352,300
| -63% | -$26.3M | 0.01% | 1919 |
|
|
2015
Q4 | $61M | Sell |
562,300
-68,700
| -11% | -$7.66M | 0.02% | 972 |
|
|
2015
Q3 | $69.6M | Buy |
631,000
+481,300
| +322% | +$54M | 0.02% | 839 |
|
|
2015
Q2 | $15.6M | Sell |
149,700
-48,300
| -24% | -$5M | ﹤0.01% | 1991 |
|
|
2015
Q1 | $18.1M | Buy |
+198,000
| New | +$16.4M | 0.01% | 1829 |
|
|
2014
Q4 | – | Sell |
-191,600
| Closed | -$9.4M | – | 7201 |
|
|
2014
Q3 | $9.4M | Buy |
191,600
+163,500
| +582% | +$8.2M | ﹤0.01% | 2413 |
|
|
2014
Q2 | $1.59M | Sell |
28,100
-91,900
| -77% | -$4.69M | ﹤0.01% | 4227 |
|
|
2014
Q1 | $6.42M | Sell |
120,000
-32,000
| -21% | -$1.99M | ﹤0.01% | 2752 |
|
|
2013
Q4 | $7.7M | Buy |
152,000
+150,000
| +7,500% | +$6.53M | ﹤0.01% | 2609 |
|
|
2013
Q3 | $76K | Sell |
2,000
-98,000
| -98% | -$2.89M | ﹤0.01% | 6225 |
|
|
2013
Q2 | $2.2M | Buy |
+100,000
| New | +$2.18M | ﹤0.01% | 3631 |
|
Other funds holding INCY
BBA
VCM
VPM
Goldman Sachs's INCY Position: Q1 2026 in Review
Goldman Sachs increased its Incyte (INCY) stake by 83% in Q1 2026, buying an estimated $107M and bringing the position to 2,351,221 shares worth $221M. The position accounts for 0.03% of the portfolio, ranked #638.
Goldman Sachs first reported a position in INCY in Q2 2013 and has held it in 52 quarters since. The position peaked at $312M in Q4 2019. 810 funds tracked by Wall St. Rank hold INCY as of Q1 2026.
- Goldman Sachs held 2,351,221 shares of Incyte worth $221M as of Q1 2026.
- Goldman Sachs bought 1,067,527 Incyte shares in Q1 2026, an estimated $107M.
- Incyte made up 0.03% of Goldman Sachs's portfolio in Q1 2026, its #638 holding.
- Goldman Sachs first reported a position in Incyte in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Incyte position peaked at $312M in Q4 2019.
- 810 funds tracked by Wall St. Rank held Incyte as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.